206 related articles for article (PubMed ID: 15183159)
1. Evaluating the validity of animal models for research into therapies for immune-based disorders.
't Hart BA; Amor S; Jonker M
Drug Discov Today; 2004 Jun; 9(12):517-24. PubMed ID: 15183159
[TBL] [Abstract][Full Text] [Related]
2. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
Steinman L; Zamvil SS
Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
[TBL] [Abstract][Full Text] [Related]
3. Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis.
't Hart BA; Hintzen RQ; Laman JD
Neurodegener Dis; 2008; 5(1):38-52. PubMed ID: 18075274
[TBL] [Abstract][Full Text] [Related]
4. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
Arnett HA; Viney JL
Adv Drug Deliv Rev; 2007 Sep; 59(11):1084-92. PubMed ID: 17804112
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models.
Leung PS; Shu SA; Kenny TP; Wu PY; Tao MH
Autoimmun Rev; 2010 Mar; 9(5):A400-5. PubMed ID: 20035901
[TBL] [Abstract][Full Text] [Related]
6. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
Bolton C
Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249
[TBL] [Abstract][Full Text] [Related]
7. New directions in MS therapeutics: vehicles of hope.
Fox RJ; Ransohoff RM
Trends Immunol; 2004 Dec; 25(12):632-6. PubMed ID: 15530830
[TBL] [Abstract][Full Text] [Related]
8. Copolymer 1 from the laboratory to FDA.
Teitelbaum D; Sela M; Arnon R
Isr J Med Sci; 1997 Apr; 33(4):280-4. PubMed ID: 9347880
[No Abstract] [Full Text] [Related]
9. Drug insight: using monoclonal antibodies to treat multiple sclerosis.
Hohlfeld R; Wekerle H
Nat Clin Pract Neurol; 2005 Nov; 1(1):34-44. PubMed ID: 16932490
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
Karussis D; Slavin S
J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
[TBL] [Abstract][Full Text] [Related]
11. Immunopathogenesis and immunotherapy of multiple sclerosis.
Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-modifying therapies in immune disorders.
Romanelli F
JAAPA; 2002 Feb; 15(2):25-8, 31-4. PubMed ID: 11917757
[No Abstract] [Full Text] [Related]
13. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Reichardt HM; Gold R; Lühder F
Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
[TBL] [Abstract][Full Text] [Related]
14. Animal models for multiple sclerosis.
Owens T
Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
[No Abstract] [Full Text] [Related]
15. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis.
Ransohoff RM
Trends Immunol; 2006 Apr; 27(4):167-8. PubMed ID: 16513422
[No Abstract] [Full Text] [Related]
16. [From magic bullets to real drugs--immunotherapy available on the pharmacy's shelves].
Veromaa T
Duodecim; 2003; 119(8):793-800. PubMed ID: 12806743
[No Abstract] [Full Text] [Related]
17. From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.
Steinman L; Lindsey JW; Alters S; Hodgkinson S
Immunol Ser; 1993; 59():253-60. PubMed ID: 8461390
[No Abstract] [Full Text] [Related]
18. Autoimmune diseases. The B cell slayer.
Matthews R
Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
[No Abstract] [Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of immunostimulatory monoclonal antibodies.
Gray JC; Johnson PW; Glennie MJ
Clin Sci (Lond); 2006 Aug; 111(2):93-106. PubMed ID: 16831129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
